五星体育直播

Nov 08, 2018 4:05 pm EST

五星体育直播 Reports Third Quarter 2018 Financial Results

Nov 08, 2018 7:00 am EST

五星体育直播 Announces Results of Phase 1a Clinical Trial with CDX-6114

Nov 07, 2018 4:05 pm EST

五星体育直播 to Present at Two Investment Conferences in November

Nov 01, 2018 7:00 am EDT

五星体育直播 to Hold Third Quarter 2018 Conference Call on November 8

Oct 01, 2018 7:00 am EDT

五星体育直播 Appoints Claus Ladefoged to Global Enzyme Business Development Role

Aug 29, 2018 7:00 am EDT

五星体育直播 to Present at Three Investment Conferences in September

Aug 08, 2018 4:05 pm EDT

五星体育直播 Reports Second Quarter 2018 Financial Results

Aug 01, 2018 7:00 am EDT

五星体育直播 to Hold Second Quarter 2018 Conference Call on August 8

Jul 11, 2018 7:00 am EDT

五星体育直播 Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

Jul 09, 2018 8:00 am EDT

五星体育直播 Doses First Subjects in Phase 1a Trial of CDX-6114

rss_feed News RSS